Chondroitin sulfate E downregulates N-cadherin and suppresses myotube formation

Fumi Satoh1, Akihiro Sugiura1, Jiro Tashiro1

  • 1Department of Veterinary Anatomy, Faculty of Agriculture, Tottori University, Tottori, Japan.

Insights

Chondroitin sulfate-E (CS-E) inhibits muscle fiber formation by downregulating N-cadherin. This protein is crucial for myoblast fusion, suggesting a new mechanism for impaired myogenesis.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Background:

  • Myogenesis, the process of muscle fiber formation, is essential for muscle development and repair.
  • Glycoproteins like chondroitin sulfate (CS) play regulatory roles in cellular processes, including myogenesis.
  • Specific CS modifications, such as CS-E, may influence myoblast differentiation and fusion.

Purpose of the Study:

  • To elucidate the molecular mechanism by which CS-E suppresses myotube formation.
  • To investigate the role of N-cadherin in CS-E-mediated inhibition of myogenesis.

Main Methods:

  • Utilized the C2C12 myoblast cell line for in vitro studies.
  • Treated differentiated myoblasts with CS-E (0.1 mg/ml) for nine days.
  • Assessed myotube morphology, myosin heavy chain expression, phospho-cofilin levels, and N-cadherin expression at both mRNA and protein levels.

Main Results:

  • CS-E treatment resulted in rounded, multinucleated myotubes positive for myosin heavy chain.
  • Phospho-cofilin levels did not differ between CS-E treated and control groups.
  • N-cadherin expression was significantly downregulated at both mRNA and protein levels in response to CS-E treatment.

Conclusions:

  • CS-E significantly inhibits myotube formation in C2C12 cells.
  • Downregulation of N-cadherin is identified as a key mechanism underlying CS-E-induced suppression of myogenesis.
  • These findings highlight N-cadherin's critical role in myoblast fusion and its potential as a target for modulating muscle formation.

Related Concept Videos

Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
3.2K
Structure of Cadherins01:25

Structure of Cadherins

The cadherins were one of the first cell adhesion molecules discovered; the term “cadherins”   is based on their calcium-dependent adhering properties. The first cadherins discovered on the epithelial, neuronal, and placental cells were named E-cadherin, P-cadherin, and N-cadherin, respectively. These classical cadherins share sequence and structural similarities. Other cadherins, including those involved in cell signaling, are grouped into non-classical cadherins. This...
3.6K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.2K
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action01:17

Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action

Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
2.2K